Skip to main content
Top
Published in: Inflammation Research 2/2005

01-02-2005 | Original Research Paper

Agonist and antagonist dual effect of the cross-linked S19 ribosomal protein dimer in the C5a receptor-mediated respiratory burst reaction of phagocytic leukocytes

Authors: I. Revollo, H. Nishiura, Y. Shibuya, Y. Oda, N. Nishino, T. Yamamoto

Published in: Inflammation Research | Issue 2/2005

Login to get access
Metadata
Title
Agonist and antagonist dual effect of the cross-linked S19 ribosomal protein dimer in the C5a receptor-mediated respiratory burst reaction of phagocytic leukocytes
Authors
I. Revollo
H. Nishiura
Y. Shibuya
Y. Oda
N. Nishino
T. Yamamoto
Publication date
01-02-2005
Publisher
Birkhäuser-Verlag
Published in
Inflammation Research / Issue 2/2005
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-004-1327-4

Other articles of this Issue 2/2005

Inflammation Research 2/2005 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.